EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
- |
Mus musculus |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
- |
Homo sapiens |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
stereospecific, unsaturated acyl-CoA preferred over saturated species |
Mus musculus |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
i.e. plasmanylcholine |
? |
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
stereospecific, unsaturated acyl-CoA preferred over saturated species |
Oryctolagus cuniculus |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
i.e. plasmanylcholine |
? |
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
i.e. lysophospholipid or lysoPAF |
Mus musculus |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
i.e. plasmanylcholine |
? |
2.3.1.63 | acyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
i.e. lysophospholipid or lysoPAF |
Oryctolagus cuniculus |
CoA + 2-acyl-1-alkyl-sn-glycero-3-phosphocholine |
i.e. plasmanylcholine |
? |
2.3.1.63 | arachidonoyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
specific for polyunsaturated fatty acids |
Mus musculus |
CoA + 2-arachidonoyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |
2.3.1.63 | arachidonoyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
Ehrlich ascites tumor cells |
Mus musculus |
CoA + 2-arachidonoyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |
2.3.1.63 | linolenoyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
- |
Mus musculus |
CoA + 2-linolenoyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |
2.3.1.63 | linolenoyl-CoA + 1-alkyl-sn-glycero-3-phosphocholine |
- |
Oryctolagus cuniculus |
CoA + 2-linolenoyl-1-alkyl-sn-glycero-3-phosphocholine |
- |
? |